414 related articles for article (PubMed ID: 30306212)
1. The Janus face of HMGB1 in heart disease: a necessary update.
Raucci A; Di Maggio S; Scavello F; D'Ambrosio A; Bianchi ME; Capogrossi MC
Cell Mol Life Sci; 2019 Jan; 76(2):211-229. PubMed ID: 30306212
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 and repair: focus on the heart.
Pellegrini L; Foglio E; Pontemezzo E; Germani A; Russo MA; Limana F
Pharmacol Ther; 2019 Apr; 196():160-182. PubMed ID: 30529040
[TBL] [Abstract][Full Text] [Related]
3. HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction.
Foglio E; Pellegrini L; Russo MA; Limana F
Cells; 2022 Jan; 11(2):. PubMed ID: 35053332
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of high mobility group box-1 in ischemic injury and tissue regeneration.
Biscetti F; Ghirlanda G; Flex A
Curr Vasc Pharmacol; 2011 Nov; 9(6):677-81. PubMed ID: 21692740
[TBL] [Abstract][Full Text] [Related]
5. High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases.
Taverna S; Tonacci A; Ferraro M; Cammarata G; Cuttitta G; Bucchieri S; Pace E; Gangemi S
Cells; 2022 Mar; 11(5):. PubMed ID: 35269471
[TBL] [Abstract][Full Text] [Related]
6. Differential Regulation of Damage-Associated Molecular Pattern Release in a Mouse Model of Skeletal Muscle Ischemia/Reperfusion Injury.
Furubeppu H; Ito T; Kakuuchi M; Yasuda T; Kamikokuryo C; Yamada S; Maruyama I; Kakihana Y
Front Immunol; 2021; 12():628822. PubMed ID: 34381442
[TBL] [Abstract][Full Text] [Related]
7. Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo.
Loukili N; Rosenblatt-Velin N; Li J; Clerc S; Pacher P; Feihl F; Waeber B; Liaudet L
Cardiovasc Res; 2011 Feb; 89(3):586-94. PubMed ID: 21113057
[TBL] [Abstract][Full Text] [Related]
8. The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.
Wang M; Gauthier A; Daley L; Dial K; Wu J; Woo J; Lin M; Ashby C; Mantell LL
Antioxid Redox Signal; 2019 Nov; 31(13):954-993. PubMed ID: 31184204
[No Abstract] [Full Text] [Related]
9. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis.
Liu FY; Fan D; Yang Z; Tang N; Guo Z; Ma SQ; Ma ZG; Wu HM; Deng W; Tang QZ
Cell Death Dis; 2019 Jun; 10(7):480. PubMed ID: 31209243
[TBL] [Abstract][Full Text] [Related]
10. The Role of HMGB1 in Rheumatic Diseases.
Dong Y; Ming B; Dong L
Front Immunol; 2022; 13():815257. PubMed ID: 35250993
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells.
Andersson U; Yang H; Harris H
Semin Immunol; 2018 Aug; 38():40-48. PubMed ID: 29530410
[TBL] [Abstract][Full Text] [Related]
12. Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction.
Di Maggio S; Milano G; De Marchis F; D'Ambrosio A; Bertolotti M; Palacios BS; Badi I; Sommariva E; Pompilio G; Capogrossi MC; Raucci A
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2693-2704. PubMed ID: 28716707
[TBL] [Abstract][Full Text] [Related]
13. HMGB1 as a therapeutic target in disease.
Xue J; Suarez JS; Minaai M; Li S; Gaudino G; Pass HI; Carbone M; Yang H
J Cell Physiol; 2021 May; 236(5):3406-3419. PubMed ID: 33107103
[TBL] [Abstract][Full Text] [Related]
14. Targeting Inflammation Driven by HMGB1.
Yang H; Wang H; Andersson U
Front Immunol; 2020; 11():484. PubMed ID: 32265930
[TBL] [Abstract][Full Text] [Related]
15. High-mobility group box 1, oxidative stress, and disease.
Tang D; Kang R; Zeh HJ; Lotze MT
Antioxid Redox Signal; 2011 Apr; 14(7):1315-35. PubMed ID: 20969478
[TBL] [Abstract][Full Text] [Related]
16. Critical role of RAGE and HMGB1 in inflammatory heart disease.
Bangert A; Andrassy M; Müller AM; Bockstahler M; Fischer A; Volz CH; Leib C; Göser S; Korkmaz-Icöz S; Zittrich S; Jungmann A; Lasitschka F; Pfitzer G; Müller OJ; Katus HA; Kaya Z
Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E155-64. PubMed ID: 26715748
[TBL] [Abstract][Full Text] [Related]
17. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation.
Limana F; Germani A; Zacheo A; Kajstura J; Di Carlo A; Borsellino G; Leoni O; Palumbo R; Battistini L; Rastaldo R; Müller S; Pompilio G; Anversa P; Bianchi ME; Capogrossi MC
Circ Res; 2005 Oct; 97(8):e73-83. PubMed ID: 16166556
[TBL] [Abstract][Full Text] [Related]
18. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart.
Takahashi K; Fukushima S; Yamahara K; Yashiro K; Shintani Y; Coppen SR; Salem HK; Brouilette SW; Yacoub MH; Suzuki K
Circulation; 2008 Sep; 118(14 Suppl):S106-14. PubMed ID: 18824741
[TBL] [Abstract][Full Text] [Related]
19. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling.
Paudel YN; Angelopoulou E; Piperi C; Balasubramaniam VRMT; Othman I; Shaikh MF
Eur J Pharmacol; 2019 Sep; 858():172487. PubMed ID: 31229535
[TBL] [Abstract][Full Text] [Related]
20. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
